Table 1.
Characteristics of the patientsa
| Patient | Age (yr) | BW (kg) | Sex | SCR (μM) | CLCR (ml/min) | Combined drugs |
|---|---|---|---|---|---|---|
| 1 | 20 | 56.7 | M | 57 | 147.6 | Salbutamol, fluticasone, salmeterol, ergocalciferol, vitamin E, colistin, pancreatic enzymes, omeprazole |
| 2 | 17 | 47 | M | 61 | 117.1 | Terbutaline, metoclopramide, ergocalciferol, tobramycin, omeprazole, vitamin E, vitamin K, pancreatic enzymes |
| 3 | 28 | 48 | F | 55 | 102.3 | Pancreatic enzymes, insulin, cetirizine, paroxetine, omeprazole |
| 4 | 33 | 58 | M | 75 | 102.6 | Salbutamol, terbutaline, fluticasone, salmeterol, pancreatic enzymes, azithromycin, ceftazidime, netilmicin, ursodesoxycholic acid |
| 5 | 34 | 49 | F | NA | NA | Fluticasone, salmeterol, salbutamol, azithromycin, ceftazidime, netilmicin |
| 6 | 33 | 51 | F | 69 | 83.6 | Salmeterol, ursodesoxycholic acid, heparin, vitamin E, repaglinide, insulin, aztreonam, acyclovir, netilmicin |
| Mean ± SD | 27.7 ± 7.1 | 51.6 ± 4.7 | 63.4 ± 8.4 | 110.6 ± 23.8 |
a
M, male; F, female; NA, not available.